Also known as a CTA. Documentation required by regulatory authorities in many countries outside the U.S. seeking authorization to move from preclinical (animal) studies to clinical (human) trials to investigate an experimental treatment. A CTA is considered a regulatory authority equivalent to an Investigational New Drug (IND) application in the U.S.